BG
Bunge Global S.A.
BG has lower modeled downside risk, despite its lower overall score.
CELH
Celsius Holdings, Inc.
CELH has the edge over BG overall, supported by stronger valuation and stronger fundamentals.
BG Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Weak |
BG's revenue is currently healthy, and its profitability is stable, but its cash flow and balance sheet are under pressure.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
BG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7x | $41.36 | -59% |
| Fair | 9.2x | $54.65 | -45% |
| Forward | 9.3x | $99.98 | — |
| Expensive | 16x | $97.75 | -2.2% |
| Current | 17x | $99.98 | — |
Historical ranges are pointers, not guarantees.
BG's PE is in its expensive range at 17x. If earnings grow as analysts expect, today's price would be 9.3x next year's earnings, in its fair range.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH has the edge over BG in the historical PE scenario, which offers more potential upside but is not a forecast.
BG Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BG, with profitability improving.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
BG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $10.80 | +81% |
| Q3 2026 | $5.95 | -36% |
| Q2 2026 | $5.15 | -49% |
| Q1 2026 | $4.29 | -46% |
| Q4 2025 | $5.42 | -33% |
| Q3 2025 | $9.29 | +18% |
| Q2 2025 | $10.01 | +14% |
| Q1 2025 | $7.88 | -37% |
| Q4 2024 | $8.08 | -46% |
BG has the edge over CELH on earnings, with stronger typical year-over-year growth.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
BG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $23.8B | +7.4% |
| Q2 2026 | $24B | +88% |
| Q1 2026 | $21.9B | +88% |
| Q4 2025 | $23.8B | +75% |
| Q3 2025 | $22.2B | +72% |
| Q2 2025 | $12.8B | -3.6% |
| Q1 2025 | $11.6B | -13% |
| Q4 2024 | $13.5B | -9.3% |
BG's revenue has grown year over year for five quarters in a row: $23.8B last quarter, up 7.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.2% | +0.9 points |
| Q2 2026 | 3.9% | 0 points |
| Q1 2026 | 0.3% | -2.2 points |
| Q4 2025 | 0.4% | -5 points |
| Q3 2025 | 1.2% | -1.3 points |
| Q2 2025 | 3.9% | +3.1 points |
| Q1 2025 | 2.4% | -0.3 points |
| Q4 2024 | 5.4% | N/A |
BG's operating margin was 2.2% last quarter, up 0.9 points from the same quarter a year ago.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over BG on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH has the edge over BG on profitability, with a higher operating margin.
BG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -505% |
| Q2 2026 | -$1B | +$450M |
| Q1 2026 | -$877M | -$282M |
| Q4 2025 | $809M | +43% |
| Q3 2025 | $385M | -60% |
| Q2 2025 | -$1.5B | +$293M |
| Q1 2025 | -$595M | -178% |
| Q3 2024 | $973M | -13% |
BG has burned cash in most quarters: −$2.7B over the past year, against −$1.1B the year before.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH has the edge over BG on cash generation, producing positive trailing cash flow while its opponent burns cash.
BG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.7% | -1.3M shares |
| 1 year | -2.2% | -4.4M shares |
| 3 years | +28% | +42.8M shares |
| 5 years | +27% | +41.5M shares |
| Available history | +37% | +52M shares |
BG has the edge over CELH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2023 | $466M |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has 255M diluted shares, down 1.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
BG Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.3x | High |
| Q2 2026 | 6.3x | High |
| Q1 2026 | 7.9x | High |
| Q4 2025 | 7.0x | High |
| Q3 2025 | 6.0x | High |
| Q2 2025 | 1.9x | Healthy |
| Q1 2025 | 1.8x | Healthy |
| Q4 2024 | 1.5x | Healthy |
BG's net debt is about 6.3 years of its operating earnings (EBITDA), up from 6.0 years a year ago.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over BG on leverage, with a lower net debt burden relative to earnings.
BG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.8 | Neutral |
| Stochastic | 16.5 | Oversold |
BG's weekly RSI is 41 (neutral) and its Stochastic is 17 (oversold).
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
BG PE vs Consumer Defensive Sector
| Metric | BG | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 19x | 14% below |
| PE % | 84 | 18 | 66 pts above |
BG has the edge over CELH on valuation relative to its sector.
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
BG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $102.9 | 2.9% below |
| 20 week MA | $109.9 | 9.1% below |
| 50 week MA | $113.1 | 12% below |
| 100 week MA | $97.0 | 3.1% above |
| 200 week MA | $98.2 | 1.8% above |
BG has slipped below its 8-, 20- and 50-week averages, though it's still 1.8% above its 200-week average.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
BG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $57.4 | $64.3 | +12% |
| 2021 | $64.3 | $90.2 | +40% |
| 2022 | $90.2 | $99.0 | +9.8% |
| 2023 | $99.0 | $101.0 | +2% |
| 2024 | $101.0 | $78.1 | -23% |
| 2025 | $78.1 | $89.1 | +14% |
| 2026 YTD | $89.1 | $100.0 | +12% |
BG has the edge over CELH on returns for 2026, with the stronger performance.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.